ARCADIS NV (ARCAD.AS)

NL0006237562 - Common Stock

63.8  +0.25 (+0.39%)

Fundamental Rating

3

Overall ARCAD gets a fundamental rating of 3 out of 10. We evaluated ARCAD against 30 industry peers in the Professional Services industry. ARCAD has an average financial health and profitability rating. ARCAD does not seem to be growing, but still is valued expensively.



5

1. Profitability

1.1 Basic Checks

ARCAD had positive earnings in the past year.
In the past year ARCAD had a positive cash flow from operations.
In the past 5 years ARCAD has always been profitable.
In the past 5 years ARCAD always reported a positive cash flow from operatings.

1.2 Ratios

ARCAD has a Return On Assets of 4.23%. This is comparable to the rest of the industry: ARCAD outperforms 44.44% of its industry peers.
ARCAD has a Return On Equity (15.04%) which is comparable to the rest of the industry.
ARCAD has a Return On Invested Capital (9.25%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for ARCAD is below the industry average of 11.78%.
The last Return On Invested Capital (9.25%) for ARCAD is above the 3 year average (9.02%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.23%
ROE 15.04%
ROIC 9.25%
ROA(3y)4.6%
ROA(5y)2.98%
ROE(3y)14.89%
ROE(5y)9.62%
ROIC(3y)9.02%
ROIC(5y)8.59%

1.3 Margins

ARCAD has a Profit Margin of 4.26%. This is comparable to the rest of the industry: ARCAD outperforms 55.56% of its industry peers.
In the last couple of years the Profit Margin of ARCAD has grown nicely.
Looking at the Operating Margin, with a value of 8.06%, ARCAD is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
ARCAD's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.06%
PM (TTM) 4.26%
GM N/A
OM growth 3Y0.26%
OM growth 5Y7.36%
PM growth 3Y77.81%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ARCAD is still creating some value.
The number of shares outstanding for ARCAD has been increased compared to 1 year ago.
The number of shares outstanding for ARCAD has been increased compared to 5 years ago.
Compared to 1 year ago, ARCAD has an improved debt to assets ratio.

2.2 Solvency

ARCAD has an Altman-Z score of 2.92. This is not the best score and indicates that ARCAD is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.92, ARCAD is in line with its industry, outperforming 48.15% of the companies in the same industry.
ARCAD has a debt to FCF ratio of 4.34. This is a neutral value as ARCAD would need 4.34 years to pay back of all of its debts.
ARCAD has a Debt to FCF ratio of 4.34. This is comparable to the rest of the industry: ARCAD outperforms 44.44% of its industry peers.
A Debt/Equity ratio of 1.03 is on the high side and indicates that ARCAD has dependencies on debt financing.
ARCAD has a Debt to Equity ratio (1.03) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 4.34
Altman-Z 2.92
ROIC/WACC1.4
WACC6.61%

2.3 Liquidity

A Current Ratio of 1.20 indicates that ARCAD should not have too much problems paying its short term obligations.
ARCAD has a Current ratio (1.20) which is in line with its industry peers.
A Quick Ratio of 1.20 indicates that ARCAD should not have too much problems paying its short term obligations.
ARCAD has a better Quick ratio (1.20) than 62.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.2

1

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.36% over the past year.
Looking at the last year, ARCAD shows a small growth in Revenue. The Revenue has grown by 0.76% in the last year.
EPS 1Y (TTM)3.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)0.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, ARCAD will show a decrease in Earnings Per Share. The EPS will decrease by -5.28% on average per year.
The Revenue is expected to grow by 4.52% on average over the next years.
EPS Next Y9.71%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
EPS Next 5Y-5.28%
Revenue Next Year1.48%
Revenue Next 2Y15.79%
Revenue Next 3Y8.76%
Revenue Next 5Y4.52%

3.3 Evolution

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 41.43, ARCAD can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of ARCAD indicates a slightly more expensive valuation: ARCAD is more expensive than 74.07% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.86. ARCAD is valued slightly more expensive when compared to this.
The Price/Forward Earnings ratio is 37.12, which means the current valuation is very expensive for ARCAD.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ARCAD indicates a slightly more expensive valuation: ARCAD is more expensive than 74.07% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ARCAD to the average of the S&P500 Index (20.69), we can say ARCAD is valued expensively.
Industry RankSector Rank
PE 41.43
Fwd PE 37.12

4.2 Price Multiples

ARCAD's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as ARCAD.
Industry RankSector Rank
P/FCF 21.41
EV/EBITDA 13.8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ARCAD does not grow enough to justify the current Price/Earnings ratio.
A cheap valuation may be justified as ARCAD's earnings are expected to decrease with -7.26% in the coming years.
PEG (NY)4.27
PEG (5Y)N/A
EPS Next 2Y5.64%
EPS Next 3Y-7.26%

3

5. Dividend

5.1 Amount

ARCAD has a Yearly Dividend Yield of 1.36%.
Compared to an average industry Dividend Yield of 2.60, ARCAD has a dividend in line with its industry peers.
With a Dividend Yield of 1.36, ARCAD pays less dividend than the S&P500 average, which is at 2.29.
Industry RankSector Rank
Dividend Yield 1.36%

5.2 History

The dividend of ARCAD is nicely growing with an annual growth rate of 35.08%!
Dividend Growth(5Y)35.08%
Div Incr Years5
Div Non Decr Years5

5.3 Sustainability

41.41% of the earnings are spent on dividend by ARCAD. This is a bit on the high side, but may be sustainable.
DP41.41%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%

ARCADIS NV

AMS:ARCAD (7/24/2024, 2:56:25 PM)

63.8

+0.25 (+0.39%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.74B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.36%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 41.43
Fwd PE 37.12
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)4.27
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.23%
ROE 15.04%
ROCE
ROIC
ROICexc
ROICexgc
OM 8.06%
PM (TTM) 4.26%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.2
Quick Ratio 1.2
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)3.36%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y9.71%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)0.76%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y